|
|||||
|
|
Impact of the Affordable Care Act's Physician Payments Sunshine Act on branded statin prescribing |
|
| Authors: | Jing Li Bingxiao Wu James Flory Jeah Jung |
| Affiliation: | 1. The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle Washington, USA ; 2. Department of Economics, Rutgers University, New Brunswick New Jersey, USA ; 3. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York New York, USA ; 4. Department of Health Administration and Policy, George Mason University, Fairfax Virginia, USA |
| Abstract: | |
| Keywords: | Affordable Care Act disclosure drug industry payment prescribing Sunshine Act |